• Strategic Use of AMG 9810 in Translational TRPV1 Antagonist

  2026-06-10

  This thought-leadership article explores the mechanistic underpinnings and strategic translational applications of AMG 9810, a potent TRPV1 antagonist, in the context of metabolic stress and pain signaling. Integrating recent findings on AMPK–SQSTM1/p62 feedback loops, it provides actionable guidance for researchers seeking robust, reproducible pain mechanism data and outlines the broader implications for sensory neuron research and tumor adaptation.

• Spatial Sampling Protocols for Infection Dynamics in Ambrosi

  2026-06-09

  Masoudi et al. present a robust, adaptable protocol for spatially sampling and monitoring pathogen spread within social ambrosia beetle colonies. The study's innovation lies in integrating colony rearing, infection assays, and spatial mapping, enabling detailed analysis of disease transmission dynamics.

• Rapamycin (Sirolimus): Strategic mTOR Inhibition for Transla

  2026-06-09

  This article explores how Rapamycin (Sirolimus) enables precise modulation of mTOR signaling, providing mechanistic depth and practical guidance for translational researchers. By integrating insights from recent kinase network discoveries and validated disease models, it offers a roadmap for leveraging APExBIO’s Rapamycin in next-generation studies across oncology, immunology, and mitochondrial disease.

• Baicalin for KEAP1-NRF2/HO-1 Pathway Modulation in Research

  2026-06-08

  Baicalin, a flavone glycoside from Scutellaria baicalensis, is redefining experimental neuroplasticity and cancer research through precise KEAP1-NRF2/HO-1 pathway modulation. This guide distills recent advances, offering protocol-ready insights and troubleshooting tips for leveraging APExBIO’s high-purity Baicalin in complex bench workflows.

• Rapamycin (Sirolimus): Optimizing mTOR Inhibition in Researc

  2026-06-08

  Rapamycin (Sirolimus) stands out as a gold-standard tool for precise mTOR pathway inhibition in cell-based and in vivo models. This article delivers actionable protocols, troubleshooting strategies, and novel insights based on the latest research—empowering labs to maximize reproducibility and translational relevance in cancer, immunology, and mitochondrial disease studies.

• Asiaticoside Blocks TGF-β1-Induced MMT via Nrf2/HO-1 in HPMC

  2026-06-07

  Zhao et al. (2020) demonstrate that asiaticoside suppresses TGF-β1-induced mesothelial-mesenchymal transition and oxidative stress in human peritoneal mesothelial cells, primarily through activation of the Nrf2/HO-1 pathway and inhibition of Smad2/3 signaling. These findings provide mechanistic insights relevant for fibrosis research and highlight new avenues for modulating TGF-β-driven cellular transitions.

• hiPSC-Derived Intestinal Organoids for Pharmacokinetic Model

  2026-06-06

  This study introduces a streamlined protocol for generating human intestinal organoids from pluripotent stem cells, enabling robust in vitro pharmacokinetic studies. The findings highlight improved physiological relevance over traditional models, supporting more accurate preclinical drug evaluation.

• Applied Workflows with YC-1 (5-(1-benzyl-1H-indazol-3-yl)fur

  2026-06-05

  YC-1 stands out as a dual-function HIF-1α inhibitor and sGC activator, enabling precise modulation of hypoxia pathways and tumor angiogenesis. This guide translates recent mechanistic findings into actionable workflows, emphasizing protocol nuances and troubleshooting strategies for cancer and neuroprotection research.

• Nilotinib (AMN-107): Precision BCR-ABL Inhibitor for CML Res

  2026-06-05

  Nilotinib (AMN-107) is a highly selective tyrosine kinase inhibitor with nanomolar potency against BCR-ABL and key KIT/PDGFR mutants. Its robust solubility in DMSO and ethanol, coupled with proven activity in cell and animal models, makes it indispensable for chronic myeloid leukemia research and kinase pathway studies.

• CAY10499: Inhibitor of Human Hormone Sensitive Lipase in Lip

  2026-06-04

  CAY10499 stands apart as a precision tool for dissecting hormone sensitive lipase and monoglyceride lipase activities in advanced lipid metabolism studies. Its selectivity and robust inhibition profile empower researchers to probe immune-metabolic cross-talk and disease mechanisms with exceptional clarity.

• MAPK10 Inhibits NSCLC Metastasis via KRT16 Phosphorylation-U

  2026-06-04

  This study uncovers that mitogen-activated protein kinase 10 (MAPK10) suppresses non-small cell lung cancer (NSCLC) metastasis through phosphorylation-dependent ubiquitination and degradation of keratin 16 (KRT16). The elucidation of the MAPK10/KRT16/RNF213 axis offers a potential prognostic biomarker and therapeutic target for NSCLC.

• Macrophage EV miR-660 Drives Breast Cancer Metastasis via KL

  2026-06-03

  This study identifies a tumor-promoting mechanism in which tumor-associated macrophage-derived extracellular vesicles (EVs) deliver microRNA-660 (miR-660) to breast cancer cells, suppressing KLHL21 and activating the IKKβ/NF-κB p65 pathway. These findings clarify how the tumor microenvironment accelerates metastasis and suggest new avenues for targeted intervention in breast cancer progression.

• Cholesterol as a Scientific Benchmark in Lipid Metabolism Re

  2026-06-03

  Explore how cholesterol, the principal sterol, shapes advanced lipid metabolism research and membrane biology. This article unveils unique protocol guidance, scientific insights, and the practical impact of APExBIO’s high-purity cholesterol beyond delivery systems.

• Firefly Luciferase mRNA: Optimizing 5-moUTP Modified mRNA Wo

  2026-06-02

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) stands at the forefront of reporter assays, enabling high-sensitivity, immune-quiet gene expression readouts. Discover how its molecular innovations streamline mRNA delivery, boost translation efficiency, and overcome classical pitfalls in preclinical and translational workflows.

• Dissecting Drug Response in Cancer: Insights from In Vitro M

  2026-06-02

  Schwartz's dissertation advances cancer pharmacology by rigorously distinguishing between growth inhibition and cell death in in vitro drug response assays. This work clarifies how nuanced viability metrics can improve the evaluation of nitrogen mustard alkylating agents like chlorambucil, with direct implications for optimizing cytotoxicity studies and translational research.

14603 records 1/974 page Next 12345 下5页 Last page